Welcome to our dedicated page for Danaher Corporation SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Danaher Corporation filings document the regulatory record of a public life sciences and diagnostics company with common stock and multiple senior note series registered on the New York Stock Exchange. Its 8-K reports cover operating and financial results, material-event disclosures, capital-structure matters and material agreements, including revolving credit facilities and debt-related disclosures.
Danaher proxy materials describe shareholder voting matters, board governance, executive compensation and related annual-meeting subjects. Other filings address exchange registration changes for specific securities, ownership and governance matters, and the formal disclosure framework surrounding the company’s public securities and financing arrangements.